According to Tilray 's latest financial reports and stock price the company's current Operating Margin is -70.12%. At the end of 2022 the company had an Operating Margin of -70.13%.
Year | Operating Margin | Change |
---|---|---|
2022 | -70.13% | 4.3% |
2021 | -67.24% | 351.77% |
2020 | -14.88% | 125.56% |
2019 | -6.60% | -106.79% |
2018 | 97.13% | 358.22% |
2017 | 21.20% | -322.89% |
2016 | -9.51% | -99.2% |
2015 | -1,186.63% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -36.36% | -48.15% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -8,391.15% | 11,866.84% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.